المؤلفون: Thurgur H; Drug Science, London, UK., Lynskey M; Drug Science, London, UK., Schlag AK; Drug Science, London, UK.; Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK., Croser C, Nutt DJ; Drug Science, London, UK.; Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK., Iveson E; Stroke and Neurorehabilitation, Nuffield Health, York, UK.

المصدر: British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 Apr; Vol. 90 (4), pp. 1081-1093. Date of Electronic Publication: 2024 Jan 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Cannabidiol*/adverse effects , Cannabis*/adverse effects , COVID-19* , Hallucinogens*, Humans ; Male ; Female ; Post-Acute COVID-19 Syndrome ; Feasibility Studies ; Dronabinol/adverse effects